IXICO (LON:IXI) Shares Down 11.5% – Time to Sell?

by · The Cerbat Gem

IXICO plc (LON:IXI – Get Free Report) shares were down 11.5% on Wednesday . The company traded as low as GBX 10.84 ($0.14) and last traded at GBX 10.84 ($0.14). Approximately 673,751 shares were traded during mid-day trading, an increase of 812% from the average daily volume of 73,851 shares. The stock had previously closed at GBX 12.25 ($0.16).

IXICO Stock Down 11.5 %

The company has a debt-to-equity ratio of 3.22, a quick ratio of 4.90 and a current ratio of 3.64. The stock has a 50-day moving average of GBX 9.81 and a two-hundred day moving average of GBX 8.49. The company has a market cap of £5.24 million, a P/E ratio of -306.25, a P/E/G ratio of -0.38 and a beta of 0.86.

Insider Activity at IXICO

In related news, insider Mark Warne bought 26,370 shares of the company’s stock in a transaction dated Thursday, October 10th. The stock was purchased at an average cost of GBX 9 ($0.11) per share, with a total value of £2,373.30 ($3,007.22). 30.28% of the stock is owned by insiders.

About IXICO

(Get Free Report)

IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company’s technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer.

Further Reading